BRIDGING THE GAP BETWEEN PRECLINICAL STUDIES AND CLINICAL DATA
HUMAN TOOLS FOR HUMAN HEALTH
Human Cell Design provides human cells and services to accelerate clinically relevant scientific progress and discovery of pharmaceutical products. Our products replicate functional native human cells providing invaluable tools for humanized assay development and disease modelling.
MOLECULAR METABOLISM
The EndoC-βH1 cell line is a valid model of human beta cells and applicable for screenings to identify novel drug target candidates.
Dr. Thomas Frogne
NOVO NORDISK
CELL METABOLISM
Acute and repeated treatment with 5-PAHSA or 9-PAHSA isomers does not improve glucose control in mice.
Dr. Norbert Tennagels
SANOFI
PLOS ONE
Secretagogin is increased in plasma from type 2 diabetes patients and potentially reflects stress and islet dysfunction.
Dr. Pia Davidsson
ASTRAZENECA
MOLECULAR METABOLISM
LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept.
Dr. Axel Haup
ELI LILLY
A PATENTED CELL MATURATION PLATFORM
FOR LARGE-SCALE PRODUCTION OF FUNCTIONAL HUMAN CELLS
To overcome industrial bottlenecks and provide truly translational human cell models for R&D, Human Cell Design combines the potential of human iPSC technology or human primary cells with a patented maturation platform. Our NatLine Platform® amplifies and maturates hiPSC-derived and primary progenitor cells to provide unlimited quantities of truly mature and functional human cells. The produced terminally differentiated cells replicate native adult human cells. NatLine® platform is adapted to large-scale and reproducible production of healthy or diseased human cell models.
A PATENTED CELL MATURATION PLATFORM
FOR LARGE-SCALE PRODUCTION OF FUNCTIONAL HUMAN CELLS
To overcome industrial bottlenecks and provide truly translational human cell models for R&D, Human Cell Design combines the potential of human iPSC technology or human primary cells with a patented maturation platform. Our NatLine Platform® amplifies and maturates hiPSC-derived and primary progenitor cells to provide unlimited quantities of truly mature and functional human cells. The produced terminally differentiated cells replicate native adult human cells. NatLine® platform is adapted to large-scale and reproducible production of healthy or diseased human cell models.
VALIDATED BY OVER
INTERNATIONAL INSTITUTIONS
HUMAN BETA CELLS: HUMAN CELL DESIGN’S FIRST ACCOMPLISHMENT
Endoc-βH beta cell models represent Natline® first accomplishment. Human Cell Design’s unique set of pancreatic beta cells already led to major findings published in peer reviewed journals and have been validated by over 200 industrial and academic laboratories across the world.
VALIDATED BY OVER
INTERNATIONAL INSTITUTIONS
HUMAN BETA CELLS, HUMAN CELL DESIGN FIRST ACCOMPLISHMENT
Endoc-βH beta cell models represent Natline® first accomplishment. Human Cell Design unique set of pancreatic beta cells already led to major findings published in peer reviewed journals and have been validated by over 200 industrial and academic laboratories across the world.
TRULY TRANSLATIONAL HUMAN CELL MODELS
GETTING BETTER MEDICATION TO PATIENTS FASTER
Here at Human Cell Design, we are convinced that human cell models are the way forward to getting better medication to patients faster. Our customers in the pharmaceutical and biotech industries and in academia rely on our internationally recognized human cells to generate reproducible data and to make informed decisions early in the drug development process.
TRULY TRANSLATIONAL HUMAN CELL MODELS
GETTING BETTER MEDICATION TO PATIENTS FASTER
Here at Human Cell Design, we are convinced that human cell models are the way forward to get better medication to patients faster. Our customers in the pharmaceutical and biotech industries and in academia rely on our internationally recognized human cells to generate reproducible data and make informed decisions early in the drug development process.
